Effects of BDNF Val

Adult Brain-Derived Neurotrophic Factor / genetics Connectome Executive Function / physiology Female Genetic Predisposition to Disease Gyrus Cinguli / diagnostic imaging Humans Magnetic Resonance Imaging Male Middle Aged Nerve Net / physiopathology Neuronal Plasticity / genetics Polymorphism, Single Nucleotide Prefrontal Cortex / diagnostic imaging Schizophrenia / genetics Young Adult

Journal

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
ISSN: 1740-634X
Titre abrégé: Neuropsychopharmacology
Pays: England
ID NLM: 8904907

Informations de publication

Date de publication:
02 2019
Historique:
received: 01 06 2018
accepted: 16 10 2018
revised: 25 09 2018
pubmed: 31 10 2018
medline: 19 12 2019
entrez: 31 10 2018
Statut: ppublish

Résumé

Cognitive control represents an essential neuropsychological characteristic that allows for the rapid adaption of a changing environment by constant re-allocation of cognitive resources. This finely tuned mechanism is impaired in psychiatric disorders such as schizophrenia and contributes to cognitive deficits. Neuroimaging has highlighted the contribution of the anterior cingulate cortex (ACC) and prefrontal regions (PFC) on cognitive control and demonstrated the impact of genetic variation, as well as genetic liability for schizophrenia. In this study, we aimed to examine the influence of the functional single-nucleotide polymorphism (SNP) rs6265 of a plasticity-related neurotrophic factor gene, BDNF (Val

Identifiants

DOI: 10.1038/s41386-018-0248-9 PMID: 30375508 PMC: PMC6333795
pubmed: 30375508
doi: 10.1038/s41386-018-0248-9
pii: 10.1038/s41386-018-0248-9
pmc: PMC6333795
doi:

Substances chimiques

Brain-Derived Neurotrophic Factor 0
BDNF protein, human 7171WSG8A2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

590-597

Références

Schizophr Bull. 2008 Nov;34(6):1066-82
pubmed: 18791076
Nature. 2010 Nov 11;468(7321):194-202
pubmed: 21068827
Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):363-9
pubmed: 21305693
Neuron. 2009 Feb 26;61(4):609-20
pubmed: 19249280
Am J Med Genet B Neuropsychiatr Genet. 2016 Jan;171B(1):111-20
pubmed: 26768522
Hum Brain Mapp. 2000 Jul;10(3):120-31
pubmed: 10912591
Cortex. 2014 Jan;50:76-85
pubmed: 24074459
Arch Gen Psychiatry. 2011 Dec;68(12):1207-17
pubmed: 21810628
Exp Brain Res. 2009 Dec;199(3-4):203-34
pubmed: 19777221
J Neurolinguistics. 2016 Nov;40:112-127
pubmed: 28082765
Eur J Neurosci. 2006 Mar;23(6):1658-64
pubmed: 16553630
Neuropsychopharmacology. 2013 Feb;38(3):525-32
pubmed: 23132269
Eur Neuropsychopharmacol. 2013 Oct;23(10):1247-56
pubmed: 23194834
Science. 2000 Jun 9;288(5472):1835-8
pubmed: 10846167
Trends Cogn Sci. 2008 Mar;12(3):99-105
pubmed: 18262825
Mol Psychiatry. 2005 Feb;10(2):208-12
pubmed: 15630410
Neuroimage. 2001 Dec;14(6):1302-8
pubmed: 11707086
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Psychopharmacology (Berl). 2014 Sep;231(18):3757-64
pubmed: 24595507
Neuron. 2018 Jan 3;97(1):14-31
pubmed: 29301099
Mol Psychiatry. 2009 Aug;14(8):746-54
pubmed: 19455150
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:181-8
pubmed: 23876786
Schizophr Res. 2018 Jul;197:458-464
pubmed: 29274733
Schizophr Res. 2013 May;146(1-3):285-8
pubmed: 23433505
Neuroimage. 2011 Feb 1;54(3):2514-23
pubmed: 20946959
Cortex. 2014 Jan;50:148-61
pubmed: 23859480
Neuroimage. 2012 Oct 1;62(4):2250-60
pubmed: 22100419
J Neurochem. 2007 Jan;100(2):416-28
pubmed: 17116228
Schizophr Bull. 2017 Sep 1;43(5):1114-1122
pubmed: 28207073
Cereb Cortex. 2016 Apr;26(4):1795-803
pubmed: 26830347
Neuropsychopharmacology. 2013 Apr;38(5):846-53
pubmed: 23299932
Neuropsychology. 2018 Feb;32(2):199-205
pubmed: 28857598
Nat Neurosci. 2005 Dec;8(12):1784-90
pubmed: 16286928
J Neurosci. 2005 Jun 29;25(26):6156-66
pubmed: 15987945
Schizophr Bull. 2017 May 1;43(3):665-672
pubmed: 27262112
Curr Opin Neurobiol. 2016 Feb;36:7-14
pubmed: 26276700
Clin Psychopharmacol Neurosci. 2016 Aug 31;14(3):270-8
pubmed: 27489381
Neurosci Biobehav Rev. 2015 Apr;51:15-30
pubmed: 25562189
Psychother Psychosom. 2006;75(2):72-84
pubmed: 16508342
PLoS One. 2014 Apr 23;9(4):e95558
pubmed: 24760076
World J Biol Psychiatry. 2018 Jun 25;:1-10
pubmed: 29938562
Cogn Affect Behav Neurosci. 2012 Jun;12(2):241-68
pubmed: 22282036
Mol Psychiatry. 2015 Aug;20(8):916-30
pubmed: 25824305
Mol Psychiatry. 2013 Aug;18(8):852-4
pubmed: 23032874
Science. 2009 May 1;324(5927):605
pubmed: 19407193
Growth Factors. 2004 Sep;22(3):123-31
pubmed: 15518235
Hum Mol Genet. 2016 Aug 1;25(15):3383-3394
pubmed: 27329760
Neuron. 2014 Jul 2;83(1):238-51
pubmed: 24991964
JAMA Psychiatry. 2016 Jun 1;73(6):598-605
pubmed: 27145286
Eur Psychiatry. 2016 Oct;38:61-69
pubmed: 27668551
Cell. 2003 Jan 24;112(2):257-69
pubmed: 12553913
Neurosci Biobehav Rev. 2016 Sep;68:218-233
pubmed: 27236043
J Neurosci. 2014 Feb 12;34(7):2645-51
pubmed: 24523553
Hum Genet. 2012 Jul;131(7):1187-95
pubmed: 22362486
J Neurosci. 2013 Apr 17;33(16):7050-6
pubmed: 23595762
J Mol Neurosci. 2012 Jul;47(3):505-10
pubmed: 22477643
Psychiatry Res. 2017 Apr;250:38-43
pubmed: 28142064

Auteurs

J I Schweiger (JI)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

E Bilek (E)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

A Schäfer (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

U Braun (U)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

C Moessnang (C)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

A Harneit (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

P Post (P)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

K Otto (K)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

N Romanczuk-Seiferth (N)

Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Mitte, Berlin, Germany.

S Erk (S)

Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Mitte, Berlin, Germany.

C Wackerhagen (C)

Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Mitte, Berlin, Germany.

M Mattheisen (M)

Department of Biomedicine and Centre for Integrative Sequencing, iSEQ Aarhus University, Aarhus, Denmark.
The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus and Copenhagen, Denmark.

T W Mühleisen (TW)

Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany.
Department of Biomedicine, University of Basel, Basel, Switzerland.

S Cichon (S)

Institute of Neuroscience and Medicine (INM-1), Research Centre Jülich, Jülich, Germany.
Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

M M Nöthen (MM)

Institute of Human Genetics, University of Bonn, Sigmund-Freud-Str. 25, Bonn, 53127, Germany.
Department of Genomics, Life & Brain Center, University of Bonn, Sigmund-Freud-Str. 25, Bonn, 53127, Germany.

J Frank (J)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

S H Witt (SH)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

M Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

A Heinz (A)

Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Mitte, Berlin, Germany.

H Walter (H)

Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Campus Mitte, Berlin, Germany.

A Meyer-Lindenberg (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

H Tost (H)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. heike.tost@zi-mannheim.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Effects of BDNF Val
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Facteurs de croissance nerveuse › Facteur neurotrophique dérivé du cerveau › Effects of BDNF Val
questionsmedicales.fr › Techniques d'investigation › Neuroimagerie › Neuroimagerie fonctionnelle › Cartographie cérébrale › Connectome › Effects of BDNF Val
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Fonction exécutive › Effects of BDNF Val
questionsmedicales.fr › Phénomènes génétiques › Génotype › Prédisposition génétique à une maladie › Effects of BDNF Val
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Télencéphale › Cerveau › Cortex cérébral › Lobe limbique › Gyrus du cingulum › Effects of BDNF Val
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Effects of BDNF Val
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Tomographie › Imagerie par résonance magnétique › Effects of BDNF Val
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Effects of BDNF Val
questionsmedicales.fr › Système nerveux › Réseau nerveux › Effects of BDNF Val
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Plasticité neuronale › Effects of BDNF Val
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Polymorphisme de nucléotide simple › Effects of BDNF Val
questionsmedicales.fr › Système nerveux › Système nerveux central › Encéphale › Prosencéphale › Télencéphale › Cerveau › Cortex cérébral › Lobe frontal › Cortex préfrontal › Effects of BDNF Val
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Schizophrénie › Effects of BDNF Val
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Effects of BDNF Val